Synthesis of novel 17-triazolyl-androst-5-en-3-ol epimers via Cu(I)-catalyzed azide-alkyne cycloaddition and their inhibitory effect on 17α-hydroxylase/C17,20-lyase

被引:4
作者
Kiss, Anita [1 ]
Herman, Bianka Edina [2 ]
Gorbe, Tamas [3 ]
Mernyak, Erzsebet [1 ]
Molnar, Barnabas [1 ]
Wolfling, Janos [1 ]
Szecsi, Mihaly [2 ]
Schneider, Gyula [1 ]
机构
[1] Univ Szeged, Dept Organ Chem, Dom Ter 8, H-6720 Szeged, Hungary
[2] Univ Szeged, Dept Med 1, Koranyi Fasor 8-10, H-6720 Szeged, Hungary
[3] Stockholm Univ, Arrhenius Lab, Organ Chem, S-10691 Stockholm, Sweden
基金
匈牙利科学研究基金会;
关键词
Azide-alkyne cycloaddition; 17; alpha-; and; beta-azido-androst-5-ene; Inhibitory effect; Chemoselectivity; NEIGHBORING GROUP PARTICIPATION; PROSTATE-CANCER; IN-VITRO; CYP17; INHIBITORS; POTENTIAL AGENTS; DERIVATIVES; P450(17-ALPHA); ABIRATERONE; STEROIDS; TOK-001;
D O I
10.1016/j.steroids.2018.03.006
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The regioselective Cu(I)-catalyzed 1,3-dipolar cycloaddition of 17 alpha- and 17 beta-azidoandrost-5-en-3 beta-ol epimers (3b and 5b) with different terminal alkynes afforded novel 1,4-substituted triazolyl derivatives (8a-k and 9a-k). For the preparation of 5'-iodo-l',2',3'-triazoles (8m-n and 9m-n), an improved method was developed, directly from steroidal azides and terminal alkynes, in reaction mediated by Cul and IC1 as iodinating agents. Acetolysis and subsequent hydrolysis of 8n and 9n yielded 5'-hydroxy-l',2',3'-triazoles 8o and 9o. The inhibitory effect of 8a-o, 9a-o, 3, and 5 on rat testicular C-17,C-20-lyase was investigated by means of an in vitro radioincubation technique. The results revealed that the C-17 epimers of steroidal triazoles influence the C-17,C-20-lyase effect. Inhibitors were found only in the 17 alpha-triazolyl series (8a-o), whereas in the C-17 azide pair the 17 beta compound (5b) was more potent.
引用
收藏
页码:79 / 91
页数:13
相关论文
共 34 条
[1]   CYP17 inhibitors in prostate cancer: latest evidence and clinical potential [J].
Alex, Anitha B. ;
Pal, Sumanta K. ;
Agarwal, Neeraj .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2016, 8 (04) :267-275
[2]   Inhibitors of steroidal cytochrome P450 enzymes as targets for drug development [J].
Baston, Eckhard ;
Leroux, Frederic R. .
RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2007, 2 (01) :31-58
[3]   N-substituted Piperazinopyridylsteroid Derivatives as Abiraterone Analogues Inhibit Growth and Induce Pro-apoptosis in Human Hormone-independent Prostate Cancer Cell Lines [J].
Brossard, Dominique ;
Zhang, Ying ;
Haider, Shozeb M. ;
Sgobba, Miriam ;
Khalid, Mohamed ;
Legay, Remi ;
Duterque-Coquillaud, Martine ;
Galera, Philippe ;
Rault, Sylvain ;
Dallemagne, Patrick ;
Moslemi, Safa ;
El Kihel, Laila .
CHEMICAL BIOLOGY & DRUG DESIGN, 2013, 82 (05) :620-629
[4]   Structures of cytochrome P450 17A1 with prostate cancer drugs abiraterone and TOK-001 [J].
DeVore, Natasha M. ;
Scott, Emily E. .
NATURE, 2012, 482 (7383) :116-U149
[5]   Synthesis of novel steroidal 17α-triazolyl derivatives via Cu(I)-catalyzed azide-alkyne cycloaddition, and an evaluation of their cytotoxic activity in vitro [J].
Frank, Eva ;
Molnar, Judit ;
Zupko, Istvan ;
Kadar, Zalan ;
Woelfling, Janos .
STEROIDS, 2011, 76 (10-11) :1141-1148
[6]   Efficient conversion of primary azides to aldehydes catalyzed by active site variants of myoglobin [J].
Giovani, Simone ;
Singh, Ritesh ;
Fasan, Rudi .
CHEMICAL SCIENCE, 2016, 7 (01) :234-239
[7]   CYP17A1 inhibitors in castration-resistant prostate cancer [J].
Gomez, Lissette ;
Kovac, Jason R. ;
Lamb, Dolores J. .
STEROIDS, 2015, 95 :80-87
[8]   Novel C-17-heteroaryl steroidal CYP17 inhibitors/antiandrogens: Synthesis, in vitro biological activity, pharmacokinetics, and antitumor activity in the LAPC4 human prostate cancer xenograft model [J].
Handratta, VD ;
Vasaitis, TS ;
Njar, VCO ;
Gediya, LK ;
Kataria, R ;
Chopra, P ;
Newman, D ;
Farquhar, R ;
Guo, ZY ;
Qiu, Y ;
Brodie, AMH .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (08) :2972-2984
[9]  
Hu Q, 2014, Cancer Drug Design and Discovery, V2nd, P319, DOI DOI 10.1016/B978-0-12-396521-9.00011-5
[10]   Synthesis of D-ring-substituted (5′R)- and (5′S)-17β-pyrazolinylandrostene epimers and comparison of their potential anticancer activities [J].
Ivanyi, Zoltan ;
Szabo, Nikoletta ;
Huber, Judit ;
Woeffling, Janos ;
Zupko, Istvan ;
Szecsi, Mihaly ;
Wittmann, Tibor ;
Schneider, Gyula .
STEROIDS, 2012, 77 (05) :566-574